News

Results per Page: 20

After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign

News Releases - May 18, 2022

Increased support needed for a coordinated global HIV and COVID-19 response

News Releases - March 23, 2022

Preliminary findings from studies in South Africa indicate that Omicron has a much higher rate of asymptomatic 'carriage' than other variants of concern

News Releases - January 07, 2022

Faith initiative expands to help build bridges between community and HIV vaccine trials

News Releases - December 14, 2021

Landmark COVID-19 Vaccine Trial in Sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV

News Releases - December 13, 2021

COVID-19 Impact on Vaccine Study Community Engagement

Community Compass - December 01, 2021

Study Community Engagement BIPOC Vaccine Trials

Community Compass - December 01, 2021

A tale of two interdependent pandemics

HVTN News - September 30, 2020

Harmonizing efforts to conduct large scale COVID-19 vaccine efficacy trials

News Releases - July 09, 2020

Skilled partners in the conduct of HIV prevention trials join COVID-19 response

News Releases - May 14, 2020

Fred Hutch and NIH experts outline plan for COVID-19 vaccines

News Releases - May 11, 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, April 2020

News Releases - April 01, 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

News Releases - March 23, 2020

HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN News - March 20, 2020

HVTN COVERAGE FROM ITS HOME INSTITUTION — FRED HUTCH

News on HVTN

Test of a new 'germline-targeting' HIV vaccine prepares to launch Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus May 19, 2022

Highlights of Fred Hutch science in 2021 From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives December 20, 2021

World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor. December 1, 2021

AIDS@40: Stories of hope and heroes The people and the science devoted to stopping HIV May 27, 2021

After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign

Increased support needed for a coordinated global HIV and COVID-19 response

Preliminary findings from studies in South Africa indicate that Omicron has a much higher rate of asymptomatic 'carriage' than other variants of concern

Faith initiative expands to help build bridges between community and HIV vaccine trials

Landmark COVID-19 Vaccine Trial in Sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV

CoVPN Impact Winner

COVID-19 Impact on Vaccine Study Community Engagement

HVTN Faith Initiative 2.0

COVID-19 Vaccine Booster QA

Study Community Engagement BIPOC Vaccine Trials

A tale of two interdependent pandemics

Harmonizing efforts to conduct large scale COVID-19 vaccine efficacy trials

Skilled partners in the conduct of HIV prevention trials join COVID-19 response

Fred Hutch and NIH experts outline plan for COVID-19 vaccines

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, April 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

News on HVTN

Stories tagged COVID-19

News on HVTN